COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica : Mise à disposition du rapport financier semestriel 2019
31/07/2019
Mise à disposition du rapport financier semestriel 2019 Charenton-le-Pont, France (31 juillet 2019) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni hier, a arrêté les comptes consolidés résumés du [...]
Predictive Laboratories Announces Research Collaboration with the Preeclampsia Foundation
31/07/2019
Collaboration to expand the study of genetic factors contributing to preeclampsia and support Predictive Laboratories’ development of personalized products to detect preeclampsia risk before and during pregnancy SALT [...]
Eloxx Pharmaceuticals Announces Open Investigational New Drug Application (IND) for a Phase 2 Clinical Trial of ELX-02 in Cystic Fibrosis Patients with the G542X Mutation in the US and Protocol Endorsement from the Cystic Fibrosis Foundation (CFF)
31/07/2019
On track to report top line data from Phase 2 clinical trials for ELX-02 in cystic fibrosis and cystinosis in the U.S., Europe, Israel and Canada in 2019 Company to host webcast and conference call on August 7, 2019 at [...]
Kiadis Pharma to present at upcoming conference in August 2019
31/07/2019
Kiadis Pharma to present at upcoming conference in August 2019 Amsterdam, The Netherlands, July 31, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS) , a clinical stage [...]
Novartis Kisqali significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials
31/07/2019
In MONALEESA-3, Kisqali plus fulvestrant achieved statistically significant improvement in overall survival in post-menopausal women in first- and second-line setting Kisqali is the only CDK4/6 inhibitor proven to [...]
CBD and LED Consumer Based Algorithm Company Smart Decision, Inc. Lists on the OTC Markets
31/07/2019
Boca Raton, FL, July 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Smart Decision, Inc. (OTC Pink Markets: SDEC), a next-generation consumer-based LED & CBD algorithm innovator, is pleased to announce the listing [...]
Konica Minolta Healthcare’s Dynamic Digital Radiography Wins Inaugural Innovation Award at AHRA 2019
31/07/2019
WAYNE, N.J., July 31, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. announces that Dynamic Digital Radiography (DDR), the company’s transformative X-ray that Moves technology, won the inaugural [...]
Akari Therapeutics Announces Oral Presentation of Nomacopan Phase II Data in Patients with Bullous Pemphigoid at the 28th European Academy of Dermatology and Venereology (EADV) Congress, October 9-13, 2019
31/07/2019
NEW YORK and LONDON, July 31, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
31/07/2019
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has entered into a [...]
Hepion Pharmaceuticals Announces Research Partnership with Applied Pharmaceutical Innovation, Faculty of Pharmacy & Pharmaceutical Sciences at University of Alberta
31/07/2019
- Accelerating NASH Research Programs - EDISON, N.J., July 31, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the [...]
Generex Biotechnology Introduces Pantheon Medical, the Newest Member of the NuGenerex Family of Companies
31/07/2019
Pantheon Medical Line of Orthopedic Implants “All-in-One” Foot & Ankle Kits https://pantheonortho.com MIRAMAR, Fla., July 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: [...]
Alphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock
31/07/2019
CARLSBAD, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today [...]
LifePod and Commonwealth Care Alliance Announce Expansion of LifePod’s Proactive-Voice Service to 500 More Members
31/07/2019
Positive care outcomes and cost reductions lead LifePod and CCA to extend pilot program BOSTON, July 31, 2019 (GLOBE NEWSWIRE) -- LifePod ® Solutions, the first proactive-voice, AI-powered caregiver service and [...]
TZOA Launches Canada’s First All-in-One Smart Home Air Filtration Solution, HAVEN
31/07/2019
Capable of improving residential air quality by upwards of 90 percent, HAVEN will be available for purchase across Western Canada over the next three months in time for forest fire season air quality concerns VANCOUVER [...]
Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3
31/07/2019
MannKind announces the opening of enrollment for this final cohort before moving to phase 3 in this pediatric clinical trial WESTLAKE VILLAGE, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD [...]
Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findings
31/07/2019
Daniel P. Lundberg, Consultant to Ritter Pharmaceuticals and former Senior VP of Marketing at Salix Pharmaceuticals to address market opportunity for Phase 3, lactose intolerance drug candidate RP-G28 LOS ANGELES, July [...]
Teladoc Health Names Health Tech Veteran David Sides as Chief Operating Officer
31/07/2019
PURCHASE, NY, July 31, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced that it has named David Sides as chief operating officer. A former corporate CEO and a longtime [...]
Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors
31/07/2019
SAN DIEGO, July 31, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced initiation of a Phase 1 [...]
SeaSpine Announces Launch of Mariner® Outrigger® Revision System
31/07/2019
CARLSBAD, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Pages